Speaker: Jillian Stansbury, ND Lobelia is classic folkloric herb that continues to be explored for new applications. This session will focus on the current research on lobeline for smoking cessation and for the treatment of amphetamine, alcohol and other addictive disorders. Lobeline has a narrow therapeutic window due to the well-known emetic effects, however small doses may synergize the efficacy of other herbs in the treatment of respiratory and addictive disorders. Lobelia may even be indicated in some types of cancers by supporting chemotherapy drug activity. This session reviews some classic Lobelia formulas, the topical application of Lobelia for respiratory disorders, and reviews the ongoing research on lobeline for neurotransmitter affects, addictive disorders, and possible new drug development.